VaramirStart free · no cardSign in
PLX as of Oct 30 · 21:37 ET
PLXNYSEBiological Products, (No Diagnostic Substances)

Protalix BioTherapeutics, Inc. · Brief

Next report

12 days

Nov 12 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±20.5%
avg realized
±13.6%
Nov 14 '24±18.5%▲+13.71%×0.74
Mar 17 '25±15.1%▲+9.38%×0.62
May 9 '25±14.0%▼−40.48%×2.88
Aug 14 '25±43.2%▼−5.59%×0.13
Q3 FY25±28.3%▼−9.81%×0.35
Q1 FY26±15.2%▼−20.79%×1.37
May 13 '26±17.0%▲+1.05%×0.06
Q2 FY26±12.4%▲+7.82%×0.63
quarterimplied−45%0+45%realized×
Q2 FY26±12.4%▲+7.82%×0.63
May '26±17.0%▲+1.05%×0.06
Q1 FY26±15.2%▼−20.79%×1.37
Q3 FY25±28.3%▼−9.81%×0.35
Aug '25±43.2%▼−5.59%×0.13
May '25±14.0%▼−40.48%×2.88
2 older reports
Mar '25±15.1%▲+9.38%×0.62
Nov '24±18.5%▲+13.71%×0.74
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull2 of 3

7disclosed supplier and customer ties in SEC filingsSEC filings
100managers reporting a position in institutional filings13F · Jun 30 '26

Bear2 of 3

6 of 8recent reports where the move came in under the options implied rangeEarnings history
3 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

PLX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±17.9% into Nov 12 earnings (Oct 29 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.